Navigation Links
Universite de Montreal and Validapro Biosciences Inc. have Signed an Agreement-in-Principle
Date:5/19/2009

Universite de Montreal and Validapro Biosciences Inc. have signed an agreement-in-principle to ensure the valorization and the operation under cGMP standards of the biotherapeutic manufacturing unit located at the Faculty of veterinary medicine in St-Hyacinthe, Quebec, Canada, for human and veterinary clinical use.

Laval, Quebec (PRWEB) May 18, 2009 -- Universite de Montreal and Validapro Biosciences Inc. have signed an agreement-in-principle to ensure the valorization and the operation under cGMP standards of the biotherapeutic manufacturing unit located at the Faculty of veterinary medicine in St-Hyacinthe, Quebec, Canada, for human and veterinary clinical use.

Validapro Biosciences Inc. via its division Laborium Biopharma will utilize the clinical scale bioproduction site for research and development projects as well as for commercial applications.

This agreement demonstrates the will of Validapro Biosciences Inc. to pursue its corporative growth strategy by the development of its Global Services Center to meet the needs of the Life Sciences industry. This represents phase 2 of the creation of its clinical biomanufacturing unit operating under the strictest regulatory requirements. Through this agreement, Universite de Montreal as well as its researchers and partners, get access to these services meeting the international standards.

###

Read the full story at http://www.prweb.com/releases/2009/05/prweb2433924.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1

Related biology technology :

1. Sigma-Aldrich and the Universite de Montreal Establish Collaboration for RNA Interference Studies
2. Immtech to Present at The Bank of Montreal Healthcare Conference
3. Bionovo to Present at Bank of Montreals 2007 Focus on Healthcare Conference
4. YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
5. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
6. Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference
7. MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of States Growing Awareness of Industrys Economic Importance
8. Neurocrine Biosciences Reports First Quarter 2009 Results
9. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
10. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
11. ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Universite de Montreal and Validapro Biosciences Inc. have Signed an Agreement-in-Principle
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology:
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
Breaking Biology News(10 mins):